En Bloc Resection of Right Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus Without Caval Reconstruction: Is It Safe to Divide the Left Renal Vein?

被引:4
|
作者
Horodyski, Laura [1 ]
Gonzalez, Javier [2 ]
Tabbara, Marina M. [3 ,4 ]
Gaynor, Jeffrey J. [3 ,4 ]
Rodriguez-Cabero, Maria [2 ]
Herranz-Amo, Felipe [2 ]
Hernandez, Carlos [2 ]
Shah, Rushi [3 ,4 ]
Ciancio, Gaetano [1 ,3 ,4 ]
机构
[1] Univ Miami Miller Sch Med, Dept Urol, Miami, FL 33136 USA
[2] Hosp Gen Univ Gregorio Maranon, Serv Urol, Madrid, Spain
[3] Univ Miami Miller Sch Med, Dept Surg, Miami, FL 33136 USA
[4] Univ Miami Miller Sch Med, Jackson Mem Hosp, Miami Transplant Inst, Miami, FL 33136 USA
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
nephrectomy; inferior vena cava thrombectomy; oncology; tumor thrombus extending to inferior vena cava; renal cell carcinoma; RADICAL NEPHRECTOMY; SURGICAL-MANAGEMENT; LIGATION; CANCER;
D O I
10.3389/fonc.2022.877310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionIt has been suggested that inferior vena cava (IVC) reconstruction following resection of retroperitoneal tumors with IVC tumor thrombus (TT) is not required when adequate collateral circulation is present. There are no reports evaluating mid-term effects on renal function in these patients. The purpose of this study was to assess renal function after en bloc resection of right renal cell carcinoma (RCC) with obstructing IVC TT and the possible risks that may arise after left renal vein division. Materials and MethodsA bi-institutional retrospective review was performed over a 15-year period, assessing patients with right RCC and obstructing level II-IV TT. All patients underwent extensive evaluation and cardiology clearance, and informed consent was obtained for right radical nephrectomy and thrombectomy with or without IVC reconstruction with possible cardiopulmonary bypass (CPB). Patient demographics, tumor characteristics, intraoperative factors, complications, length of stay, and patient survival were evaluated. Preoperative creatinine was recorded, as was creatinine on the day of discharge and at 6 and 12 months postoperatively. ResultsTwenty-two patients were included in the study. Median age at surgery was 62.5 (range: 45-79) years, and 19 (86%) of the patients were men. One patient (5%) had a level II thrombus, 14 patients (64%) had a level III thrombus (IIIa, n = 3; IIIb, n = 6; IIIc, n = 3; IIId, n = 2), and seven patients (32%) had a level IV thrombus. Intraoperatively, median estimated blood loss was 1.35 (range: 0.2-25) L. The median length of hospital stay was 11 (range: 5-50) days. Median preoperative creatinine was 1.20 (range: 0.40-2.70) mg/dl, and postoperatively, median creatinine was 1.3 (range: 0.86-2.20) mg/dl. Median creatinine levels at 6 months and 12 months postoperatively were 1.10 (range: 0.5-1.8) mg/dl and 1.40 (range: 0.6-2.0) mg/dl, respectively. Four patients died (range: 0.1-1.3 years), and median postoperative follow-up among the 18 ongoing survivors (at last follow-up) was 1.5 (range: 0.5-7.0) years. ConclusionsResection of right RCC with an obstructing level II-IV TT without reconstruction of the IVC appears to not have a significant adverse effect on mid-term renal function after division of the left renal vein.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] EN BLOC RESECTION OF RIGHT RENAL CELL CARCINOMA AND INFERIOR VENA CAVA WITH TUMOR THROMBUS: IS IT SAFE TO DIVIDE THE LEFT RENAL VEIN?
    Horodyski, Laura
    Gonzalez, Javier
    Tabbara, Marina
    Gaynor, Jeffrey
    Rodriguez-Cabero, Maria
    Herranz-Amo, Felipe
    Hernandez, Carlos
    Shah, Rushi
    Ciancio, Gaetano
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E956 - E957
  • [2] Initial Series of Robotic Segmental Inferior Vena Cava Resection in Left Renal Cell Carcinoma With Caval Tumor Thrombus
    Du, Songliang
    Huang, Qingbo
    Yu, Hongkai
    Shen, Donglai
    Gu, Liangyou
    Yan, Fei
    Liu, Fengyong
    Zhang, Xu
    Ma, Xin
    Wang, Baojun
    [J]. UROLOGY, 2020, 142 : 125 - 131
  • [3] Initial Series of Robotic Segmental Inferior Vena Cava Resection in Left Renal Cell Carcinoma With Caval Tumor Thrombus
    Clark, Peter E.
    [J]. UROLOGY, 2020, 142 : 131 - 132
  • [4] Management of Renal Cell Carcinoma With Tumor Thrombus in Renal Vein and the Inferior Vena Cava
    Qi, Jun
    Gu, Zhengqin
    Chen, Fang
    Shen, Haibo
    Chen, Jianhua
    Zhang, Liang
    Wang, Weiming
    [J]. ANNALS OF VASCULAR SURGERY, 2010, 24 (08) : 1089 - 1093
  • [5] Adrenocortical carcinoma with inferior vena cava, left renal vein and right atrium tumor thrombus extension
    Annamaria, Pronio
    Silvia, Piroli
    Bernardo, Ciamberlano
    Alessandro, De Luca
    Antonino, Marullo
    Antonio, Barretta
    Giuseppe, Mazzesi
    Massimo, Rossi
    Montesani, Chiara
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2015, 15 : 137 - 139
  • [6] Initial Series of Robotic Segmental Inferior Vena Cava Resection in Left Renal Cell Carcinoma With Caval Tumor Thrombus REPLY
    Du, Songliang
    Zhang, Xu
    Ma, Xin
    Wang, Baojun
    [J]. UROLOGY, 2020, 142 : 132 - 132
  • [7] Impact of Left Renal Vein Ligation on Renal Function Following En Bloc Resection of Segmental Inferior Vena Cava and Right Kidney
    Wang, Shengzheng
    Gaurab, Pokhrel
    Cui, Jinshan
    Yu, Shuanbao
    Fan, Yafeng
    Zhu, Zhaowei
    Tao, Jin
    Zhang, Xuepei
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (07) : 4787 - 4794
  • [8] Tumor Thrombus Into the Inferior Vena Cava After Resection of Renal Cell Carcinoma: Recurrence or Tumor Thrombus Left Behind?
    Ciancio, Gaetano
    Gonzalez, Javier
    [J]. UROLOGY, 2021, 148 : E17 - E22
  • [9] En bloc mobilization of the inferior vena cava and large hypervascular right renal tumors with or without inferior vena cava thrombus: Posterior ligation of the renal artery
    Ciancio, Gaetano
    Cerwinka, Wolfgang H.
    Soloway, Mark S.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (08) : 1144 - 1146
  • [10] Resection of extensive segments of inferior vena cava without reconstruction in the treatment of renal carcinoma with inferior vena cava tumor thrombus: A case report
    Shang, Kun
    Li, Changjiu
    Chen, Jun
    Li, Ning
    He, Huadong
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2024, 38